Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
22nd May 2026 Uncategorised 0Less than a month after an FDA advisory committee recommended rejection of AstraZeneca’s novel cancer drug, Europe’s CHMP has blessed Etcamah with a positive opinion. The EMA also has signed off on Novo Nordisk’s Wegovy pill.
More: Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
Source: fierce